1. Home
  2. LANV vs NYXH Comparison

LANV vs NYXH Comparison

Compare LANV & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LANV
  • NYXH
  • Stock Information
  • Founded
  • LANV 2015
  • NYXH 2009
  • Country
  • LANV China
  • NYXH Belgium
  • Employees
  • LANV N/A
  • NYXH N/A
  • Industry
  • LANV Blank Checks
  • NYXH Medical/Dental Instruments
  • Sector
  • LANV Finance
  • NYXH Health Care
  • Exchange
  • LANV Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • LANV 258.1M
  • NYXH 222.3M
  • IPO Year
  • LANV N/A
  • NYXH 2021
  • Fundamental
  • Price
  • LANV $2.19
  • NYXH $7.75
  • Analyst Decision
  • LANV
  • NYXH Strong Buy
  • Analyst Count
  • LANV 0
  • NYXH 4
  • Target Price
  • LANV N/A
  • NYXH $14.50
  • AVG Volume (30 Days)
  • LANV 39.4K
  • NYXH 42.0K
  • Earning Date
  • LANV 08-25-2025
  • NYXH 08-05-2025
  • Dividend Yield
  • LANV N/A
  • NYXH N/A
  • EPS Growth
  • LANV N/A
  • NYXH N/A
  • EPS
  • LANV N/A
  • NYXH N/A
  • Revenue
  • LANV $340,211,202.00
  • NYXH $4,716,818.00
  • Revenue This Year
  • LANV $11.74
  • NYXH $323.07
  • Revenue Next Year
  • LANV $11.11
  • NYXH $204.30
  • P/E Ratio
  • LANV N/A
  • NYXH N/A
  • Revenue Growth
  • LANV N/A
  • NYXH N/A
  • 52 Week Low
  • LANV $0.91
  • NYXH $5.55
  • 52 Week High
  • LANV $2.69
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • LANV 53.13
  • NYXH 56.36
  • Support Level
  • LANV $2.00
  • NYXH $7.30
  • Resistance Level
  • LANV $2.51
  • NYXH $7.77
  • Average True Range (ATR)
  • LANV 0.15
  • NYXH 0.25
  • MACD
  • LANV 0.02
  • NYXH -0.04
  • Stochastic Oscillator
  • LANV 37.25
  • NYXH 62.50

About LANV Lanvin Group Holdings Limited

Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: